Main Story
-
The Ultimate Scottish Summer Bucket List Experience
With just two weeks to go until Saturday, August 15th, 2026, excitement is reaching fever pitch for the return of the Stirling Highland Games at the Stirling Sports Village. Set against the majestic backdrop of the Wallace Monument and Stirling Castle, this year’s International Gathering promises an unforgettable celebration of Scottish power, passion, and pageantry.…
Travel
Products
-
AccuSure AS9 Fully Automatic Digital Blood Pressure Monitor With Large Display
Original price was: ₹1,733.00.₹998.00Current price is: ₹998.00. -
AGEasy Max Group Fully Automatic One Touch Digital Blood Pressure Monitoring Device
Original price was: ₹1,405.00.₹949.00Current price is: ₹949.00. -
Automatic Digital Blood Pressure Monitor for Upper Arm, Large LCD Display
Original price was: ₹2,399.00.₹448.00Current price is: ₹448.00. -
Beurer German Engineering P0 13 Kid’s Pulse Oximeter I Fingertip Home Pulse Oximeter
Original price was: ₹2,745.00.₹1,538.00Current price is: ₹1,538.00. -
BPL Medical Technologies Bluetooth Enabled Arm Type Blood Pressure Monitor
Original price was: ₹6,563.00.₹5,199.00Current price is: ₹5,199.00.
Automobile
Tech
Entertainment
Health
-
More Cancer Patients Are Opting to Preserve Their Tumors
New Tumor-Preservation Service Opens in Arizona, Giving Patients the Chance to Preserve Tumor Tissue for Potential Personalized Dendritic Cell Therapy Source: More Cancer Patients Are Opting to Preserve Their Tumors
-
Axtria to Build Industry’s Largest Pharma-Specific AI Engineering Team, Scaling to 1,000 by December 2026
NEW DELHI, Aug. 13, 2026 /PRNewswire/ — Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, today announced plans to expand its Forward Deployed Engineering (FDE) organization to 1,000 engineers by December 2026, creating the industry’s largest pharma-specific AI engineering team. The expansion represents one of Axtria’s largest investments in AI…
-
Belite Bio Reports Unaudited Second Quarter 2026 Financial Results and Provides a Corporate Update
SAN DIEGO, Aug. 12, 2026 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced its financial results for the second quarter ended June 30, 2026, and provided a business…
-
ArkBio Announces China IND Approval for its Antiviral Drug-Fc Conjugate (AFC) Candidate AK0406 for Influenza Prophylaxis
SHANGHAI, Aug. 13, 2026 /PRNewswire/ — Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”) today announced that the Investigational New Drug (IND) application for AK0406 injection, the company’s first long-acting antiviral drug‑Fc conjugate (AFC) candidate for influenza prophylaxis, has been approved by the National Medical Products Administration (NMPA) of China, making AK0406 the first influenza AFC drug…
-
FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares
FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares Source: FocalTherics™ Announces Pricing of Public Offering of American Depositary Shares
-
Helfie AI Appoints Heavyweight Tech and Governance Leaders to its Board of Directors
Former Apple and Airbnb executive Patrick Gates and ex-Meta executive Sunita Parasuraman join as Non-Executive Directors, strengthening Helfie’s technology and governance. MELBOURNE, Australia, Aug. 11, 2026 /PRNewswire/ — Helfie AI (“Helfie”), an AI-powered preventative network transforming global healthcare via mobile, today announced the appointment of Patrick Gates and Sunita Parasuraman as Non-Executive Directors. Patrick Gates…
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
